Cargando...
Levodopa-carbidopa enteral suspension in advanced Parkinson’s disease: clinical evidence and experience
The duration of action of oral levodopa becomes shorter as Parkinson’s disease (PD) progresses. Patients with advanced PD may develop potentially disabling motor fluctuations and abnormal involuntary movement (dyskinesia), which cannot be managed with optimized oral or transdermal PD medications. Th...
Gardado en:
| Publicado en: | Ther Adv Neurol Disord |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5349373/ https://ncbi.nlm.nih.gov/pubmed/28344656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616681280 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|